IP Library Granted Patent US 9,682,233
Granted Patent B2
US 9,682,233 · App. 14/930,233 · Granted Jun 20, 2017

Nerve stimulation and blocking for treatment of gastrointestinal disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,682,233
App. No.
14/930,233
Granted
Jun 20, 2017
Kind
B2
Abstract

At least one of a plurality of gastrointestinal disorders is treated by stimulating an enteric nervous system of a patient to enhance a functional tone of the enteric nervous system. A treatment includes electrically stimulating a vagus nerve of the patient at a stimulation site proximal to at least one site of vagal innervation of a gastrointestinal organ. The electrical stimulation includes applying a stimulation signal at the stimulation site. An optional proximal electrical blocking signal is applied to the vagus nerve at a proximal blocking site proximal to the stimulation site. The proximal blocking signal is selected to at least partially block nerve impulses at the proximal blocking site.

Claims (10)

1. A method for treating at least one of a plurality of disorders of a gastrointestinal tract of a patient where the disorders are characterized at least in part by hyper-tonal vagal activity the method comprises applying at least one electrode adapted to be placed on a vagus nerve below a vagal innervation of the heart; delivering an electrical signal to the vagus nerve having a frequency of at least 500 Hz and having at least one parameter selected to i) at least partially downregulate efferent or afferent nerve activity of the vagus nerve, and ii) allow at least partial recovery of the nerve activity following discontinuation of the electrical signal.

2. The method of claim 1 , further comprising parameters selected to reduce pancreobilliary output.

3. The method of claim 1 , wherein the electrical signal delivered is only a downregulating signal.

4. The method of claim 1 , wherein the timing of the electrical signal is intermittent.

5. The method of claim 1 , wherein the at least one electrode is adapted to be placed on a vagal trunk.

6. The method of claim 5 , wherein the vagal trunk innervates an organ selected from the group consisting of an esophagus, stomach, pancreas, duodenum, jejunum, and ileum.

7. The method of claim 1 , wherein the at least one parameter for the electrical signal is selected from the group consisting of frequency, amplitude, pulse width, timing and duty cycle.

8. The method of claim 7 , wherein the selected parameter is timing of the electrical signal.

9. The method of claim 8 , wherein the electrical signal is applied once every ten minutes.

10. The method of claim 1 , wherein the vagus nerve comprises an anterior, a posterior, or anterior and posterior vagus nerves.

Assignments (2)
SECURITY INTEREST Recorded Jun 19, 2020
From: RESHAPE LIFESCIENCES INC.; RESHAPE MEDICAL LLC
To: ARMISTICE CAPITAL MASTER FUND LTD.
Reel/Frame 052987/0463 →
CHANGE OF NAME Recorded Mar 30, 2018
From: ENTEROMEDICS INC.
To: RESHAPE LIFESCIENCES INC.
Reel/Frame 045949/0495 →